Related by context. Frequent words. (Click for all words.) 74 Drug Application ANDA 70 Generic Version 68 FDA Accepts 66 Abbreviated New 66 Oral Solution 63 application sNDA 63 Extended Release 63 Hydrochloride 63 Extended Release Tablets 63 FDA Approval 62 ANDA 62 USFDA approval 62 Phase III Clinical Trial 61 Drug Candidate 61 FDA Approves 61 Paragraph IV certification 61 Pivotal Phase III 60 Citizen Petition 60 Par Pharmaceuticals 60 Patient Enrollment 60 sodium phosphate monobasic monohydrate 60 Marketing Authorization 60 Icatibant 60 FDA Clearance 59 Glenmark Generics 59 sNDA 59 Positive Opinion 59 Marketing Authorization Application 59 injection USP 59 Topiramate 59 FDA approvable letter 59 Injection USP 59 Factive 59 Nasal Spray 58 Full Prescribing Information 58 Complete Response 58 Drug Administration USFDA 58 Marketing Authorization Application MAA 58 Crofelemer 58 sodium phosphate dibasic anhydrous 58 Orphan Drug Status 58 Oral Suspension 58 Phase III Trial 58 Act PDUFA date 58 Surgical Adhesive 58 Ceftobiprole 57 ZALBIN 57 Somaxon Pharmaceuticals 57 pseudobulbar affect PBA 57 Onsolis 57 FDA Clears 57 Pravastatin 57 mg capsules 57 FDA Orphan Drug 57 Biologics License Application 57 Panzem R 57 ANDAs 57 fumarate 57 Biologics License Application BLA 57 Nexavar ® 56 Investigational Device Exemption 56 Pirfenidone 56 Pennsaid R 56 Anastrozole 56 Vitaros 56 Zegerid 56 FIRAZYR 56 Clinical Trial Results 56 sBLA 56 Symbyax 56 silodosin 56 Relistor 56 Completes Enrollment 56 Company Nasdaq PRGO 56 Ondansetron 56 Orphan Drug Designation 56 Focalin XR 56 New Drug Application 56 Oscient Pharmaceuticals 56 Rifaximin 56 Roxane Laboratories Inc. 56 ISTA Pharmaceuticals 56 dalbavancin 55 Pulmicort 55 supplemental Biologics License Application 55 Duramed Pharmaceuticals Inc. 55 Opana ER 55 Omeprazole 55 NOXAFIL 55 dronabinol 55 Solzira 55 antifungal agent 55 USFDA 55 Risperidone 55 fluticasone propionate 55 Mylan Pharmaceuticals Inc. 55 Emend 55 k Clearance 55 Clinical Trial Application 55 Treximet 55 Market Approval PMA